Dianthus Therapeutics announces proposed $400 million public share offering
Source: SeekingAlpha
2026-03-09 16:10:34 ET
More on Dianthus Therapeutics
- Dianthus Therapeutics, Inc. (DNTH) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript
- Dianthus Therapeutics, Inc. (DNTH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Dianthus Therapeutics, Inc. (DNTH) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Seeking Alpha’s Quant Rating on Dianthus Therapeutics
- Historical earnings data for Dianthus Therapeutics
Read the full article on Seeking Alpha
For further details see:
Dianthus Therapeutics announces proposed $400 million public share offering
Dianthus Therapeutics Inc.
NASDAQ: DNTH
DNTH Trading
1.77% G/L:
$83.78 Last:
2,117,975 Volume:
$86.55 Open:
DNTH Latest News
March 10, 2026 10:54:01 pm
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering
March 09, 2026 04:01:00 pm
Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
DNTH Stock Data
$2,196,597,434
37,892,819
0.47%
33
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
